Nat. Med. 23, 250–255 (2017); published online 19 December 2016; corrected after print 18 April 2017
In the version of this article initially published, the Acknowledgements section contained an error: “The WEBs laboratory is supported by the Deutsche Forschungsgemeinschaft grant DFG EXC 1003 (H.S.).” is incorrect. The correct sentence is: “W.E.B.'s laboratory is supported by the Deutsche Forschungsgemeinschaft grant DFG EXC 1003.” The error has been corrected in the HTML and PDF versions of the article.
Additional information
The online version of the original article can be found at 10.1038/nm.4255
Rights and permissions
About this article
Cite this article
Schneider, C., Oellerich, T., Baldauf, HM. et al. Correction: Corrigendum: SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia. Nat Med 23, 788 (2017). https://doi.org/10.1038/nm0617-788a
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm0617-788a
